社會中有疑問,為什麼先替老弱打疫苗?可以看看邏輯和外面例子。
香港疫苗供應,依賴外來供應,一句到尾,無人敢保證。
社會是我們市民的家,老人家與長期病患者,中了新冠肺炎,死亡率比其他人高,是大家都知道的。
因此,若茂叔只可以偷運幾劑的疫苗,到自己家中,被執法者拘捕之前,一定先替風險高的家人注射。
美國也是先幫老弱、醫護、和部分維持社會運作人員打針。CDC 公佈: https://www.cdc.gov/coronavirus/2019-ncov/vaccines/recommendations.html
還有,在外國,煙民爭取打針,不是離開,也不是「被離開」。
Here’s Chicago’s full list of health conditions that qualify recipients for a COVID-19 vaccination starting March 29:
Cancer (current diagnosis)
Cardiac, cardiovascular, and cerebrovascular disorders (including heart disease, coronary artery disease, and hypertension or high blood pressure)
Chronic Kidney Disease
Chronic respiratory disorders (including cystic fibrosis, moderate to severe asthma, pulmonary fibrosis, and chronic obstructive pulmonary disease/emphysema [COPD])
Diabetes (Type 1 and Type 2)
Disability: physical, developmental, visual, hearing, or mental
Neurologic conditions (including dementia)
Down Syndrome
Immunocompromised state (weakened immune system) including from blood or bone marrow transplant, immune deficiencies, HIV, use of corticosteroids, or use of other immune weakening medicines
Liver disease (including hepatitis)
Pregnancy
Obesity: BMI ≥30 kg/m2
Schizophrenia spectrum disorders
Sickle Cell Disease
「diabetes coronary artery disease」的推薦目錄:
diabetes coronary artery disease 在 臨床筆記 Facebook 的最讚貼文
#lipid #gdl
Management of Dyslipidemia for Cardiovascular Disease Risk Reduction: Synopsis of the 2020 Updated U.S. Department of Veterans Affairs and U.S. Department of Defense Clinical Practice Guideline 2020
• 治療目標是預後(心血管疾病、健康、住院、死亡),而不是血脂濃度。
• 血脂(膽固醇、LDL-C、HDL-C、TG):每 10 年檢驗一次,不需要禁食。
• 初級預防:中度劑量的 statins,不要用 PCSK9 抑制劑。高危險群者能加上地中海飲食。
• 次級預防:中度劑量的 statins,高危險群(AMI 之後、ACS 一年內、復發性 AMI/ACS/中風、糖尿病、抽煙、PAOD、PCI、CABG)病人可以用高強度 statins、加上 ezetimibe/PCSK9 抑制劑、禁食 TG > 150 mg/dL(非禁食 TG > 200 mg/dL)者能加上 VASCEPA(Icosapent Ethyl)、地中海飲食。
• 沒有幫助:CAC、CRP、ABI、apolipoproteins。
• 不要用 niacin、fibrates。
Lipitor (atorvastatin 10-20 mg/tablet), Crestor (rosuvastatin 10 mg/tablet).
1. Continue to Treat to Target Dose Not LDL-C Level
2. Use of Additional Tests to Refine Risk Prediction: Evidence Is Still Insufficient
coronary artery calcium (CAC), high-sensitivity C-reactive protein, ankle–brachial index, and apolipoprotein
3. Primary Prevention: Moderate-Dose Statin Therapy Is Still Emphasized; No to Proprotein Convertase Subtilisin/Kexin Type 9 (PCSK9) Inhibitors
No RCT directly compared high-dose with moderate-dose statin therapy in primary prevention.
4. Secondary Prevention: Moderate Statin Doses Initially, Then Stepped Intensification in Higher-Risk Patients
For higher-risk patients (recent MI or acute coronary syndrome (in the past 12 months); recurrent acute coronary syndrome, MI, or stroke; or established CVD with additional major risk factors (such as current tobacco use, diabetes, peripheral artery disease, or previous coronary artery bypass graft surgery or percutaneous coronary intervention), evidence supports the addition of ezetimibe or PCSK9 inhibitors to moderate- or high-dose statin therapy.
5. Laboratory Testing: No Routine Fasting or Monitoring Is Needed; Less Is More
We recommend measuring lipid levels no more than every 10 years. Note that previously measured lipid levels may be used reliably in serial CVD risk assessments. We do not recommend rechecking lipid levels each time CVD risk is assessed, because lipid levels remain stable within each patient over time and contribute little to predicted risk relative to other factors.
6. Physical Activity: Increased Aerobic Exercise for All and Cardiac Rehabilitation After a Recent CVD Event
7. Nutrition, Supplements, Niacin, and Fibrates: Suggest a Mediterranean Diet for High-Risk Patients, Limit Icosapent Ethyl to Secondary Prevention, Avoid Supplements and Niacin, and Avoid Adding Fibrates to Statin Therapy
https://www.acpjournals.org/doi/full/10.7326/M20-4648
diabetes coronary artery disease 在 麥特教練 x 訓練與生活 Facebook 的最佳貼文
大部分(約80%)的人一生中都會有過下背疼痛(非特異性),來看看美國肌力與體能協會(NSCA)對於下背疼痛患者的核心穩定訓練。
ttps://www.facebook.com/NSCAofficial/posts/1268497566568651
diabetes coronary artery disease 在 The Link Between Diabetes and Coronary Artery Disease 的推薦與評價
In December 2021, Get With The Guidelines®-Coronary Artery Disease (GWTG-CAD) enhanced data collection and monitoring of care for patients ... ... <看更多>